NYSE: COR
Healthcare · Medical - Distribution
Market Cap
$61.92B
52w High
$377.54
52w Low
$244.82
P/E
23.52
Volume
240.76K
Outstanding Shares
194.56M
Performance
Price vs Fundamentals
The stock rose 9.67% over the last year. Revenue grew 5.09% over the trailing twelve months. Operating margin moved from 1.09% to 1.3%. Free cash flow grew 255.65% over the trailing twelve months.
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
Operating margin currently stands at 1.3%. A decisive move in revenue — currently up 5.09% — would be the clearest signal to resolve the ambiguity.
Company profile
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets.
Valuation
Stock splits
Every 1 shares became 10
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
33
Buy
12
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 4, 2026
Q4 FY26 · EPS est $4.52 · Revenue est $88.09B
View
Dividends
$2.40/shareQuarterly5yr growth streakSafeCOR pays a dividend with a 0.75% dividend yield, 5 consecutive years of growth, growing at 5.77% annually, covered 7.3× by free cash flow.
Dividend Yield
0.75%
Annual Div / Share
$2.40
5yr CAGR
+5.77%
Doubles every ~12.4yr
Payout Ratio
17.83%
Safe
Dividend Growth Rate
3yr CAGR
+6.46%
5yr CAGR
+5.77%
10yr CAGR
+3.28%
Dividend History
Annual dividends paid per share
Income Projection
Today
$1/mo
In 5 yrs
$1/mo
In 10 yrs
$1/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$8/yr $1/mo | $10/yr+32% $1/mo | $13/yr+75% $1/mo |
Yield-on-cost grows from 0.75% → 1.32% over 10yr
Analysis
Well-covered by free cash flow
The dividend is covered 7.3× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 5.77% meaningfully outpaces inflation, compounding real income growth for long-term holders.
No strong risk signal stands out from the latest period pair.